Global coronavirus cases surpass 5 million, infections rising in South America

Published 2020-05-20, 06:31 p/m
© Reuters. FILE PHOTO: Outbreak of the coronavirus disease (COVID-19), in Rio de Janeiro

By Lisa Shumaker and Cate Cadell

(Reuters) - Global coronavirus cases surpassed 5 million on Wednesday, with Latin America overtaking the United States and Europe in the past week to report the largest portion of new daily cases globally.

It represents a new phase in the virus' spread, which initially peaked in China in February, before large-scale outbreaks followed in Europe and the United States.

Latin America accounted for around a third of the 91,000 cases reported earlier this week. Europe and the United States each accounted for just over 20%.

A large number of those new cases came from Brazil, which recently surpassed Germany, France and the United Kingdom to become the third-largest outbreak in the world, behind the United States and Russia.

Cases in Brazil are now rising at a daily pace second only to the United States.

The first 41 cases of coronavirus were confirmed in Wuhan, China, on Jan. 10 and it took the world until April 1 to reach its first million cases. Since then, about 1 million new cases are reported every two weeks, according to a Reuters tally.

At more than 5 million cases, the virus has infected more people in under six months than the annual total of severe flu cases, which the World Health Organization estimates is around 3 million to 5 million globally.

The pandemic has claimed over 326,000 lives, though the true number is thought to be higher as testing is still limited and many countries do not include fatalities outside of hospitals. Over half of the total fatalities have been recorded in Europe.

Despite the continued increase in cases, many countries are opening schools and workplaces following weeks of lockdown that have stemmed the spread.

© Reuters. FILE PHOTO: Outbreak of the coronavirus disease (COVID-19), in Rio de Janeiro

Financial markets have also been boosted slightly by promising early results from the first U.S. vaccine trial in humans.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2025 - Fusion Media Limited. All Rights Reserved.